ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan

Other Plans and Options
  • 0.79 %Nav, as on 04-07-2025

  • Previous Nav

  • Net Change on 04-07-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option 3.58 8.65 22.95 31.07 25.84 23.17
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option Jul 13, 2018 22.95 31.07 25.84 1.06 5,507.52
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 16.87 26.56 23.41 0.89 8,352.16
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 22.09 30.76 25.87 0.90 3,689.28
DSP Healthcare Fund - Direct Plan - Growth Nov 30, 2018 18.15 28.45 25.24 0.62 2,961.36
Mirae Asset Healthcare Fund Direct Growth Jul 02, 2018 18.62 25.77 24.16 0.50 2,690.55
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Dec 28, 2015 16.56 26.96 24.03 0.63 1,231.67

Fund Holdings as on 31-May-2025

  • Sun Pharmaceutical Industries Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Divi's Laboratories Ltd.

  • Cipla Ltd.

  • Aurobindo Pharma Ltd.

  • Alkem Laboratories Ltd.

  • Zydus Lifesciences Ltd.

  • Lupin Ltd.

  • Gland Pharma Ltd.

  • TREPS

  • Syngene International Ltd.

  • Pfizer Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Medplus Health Services Ltd

  • Mankind Pharma Ltd

  • Biocon Ltd.

  • Shilpa Medicare Ltd.

  • Sagility India Ltd

  • Thyrocare Technologies Ltd.

  • Advanced Enzyme Technologies Ltd.

  • Windlas Biotech Ltd.

  • Medi Assist Healthcare Services Ltd

  • Aarti Drugs Ltd.

  • Fine Organic Industries Ltd.

  • Star Health & Allied Insurance

  • Sun Pharma Advanced Research Co. Ltd

  • Yatharth Hospital & Trauma Care Services Pvt Ltd

  • Sanofi Consumer Healthcare India Ltd

  • Glenmark Pharmaceuticals Ltd.

  • Aarti Industries Ltd.

  • FDC Ltd.

  • Procter & Gamble Health Ltd.

  • Astrazeneca Pharma India Ltd.

  • Emcure Pharmaceuticals Ltd.

  • Senores Pharmaceuticals Ltd

  • Unichem Laboratories Ltd.

  • Cash Margin - Derivatives

  • Laxmi Dental Ltd.

  • Laxmi Organic Industries Ltd.

  • Net Current Assets

View More

  • Pharmaceuticals & Drugs

  • Business Support

  • Hospital & Healthcare Services

  • Miscellaneous

  • Chemicals

  • Insurance

  • Medical Equipment/Supplies/Accessories

View More

  • Cash

  • Equity

View More

About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

Scheme Analysis

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ICICI Prudential Mutual Fund. It was launched on 13-Jul-2018 and currently has an AUM of ₹5,507.52 crore. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ended up ₹0.34(0.79%)yesterday to ₹43.15.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Dharmesh Kakkad .

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100